This article was originally published in The Gray Sheet
Receives $9.7 mil. judgment plus attorneys fees against San Diego-based Genix Biotek in San Diego superior court May related to "a conspiracy" by former Syntron top managers "to steal and utilize proprietary property from Syntron" related to its diagnostic test kits, the firm explains. Genix officials Wen Young, Joe Fan, Frank Lin, George Chu, Sherman Kuo and San Diego State University Professor Long Lee are prohibited by the court to sell or manufacture test kits for six years and ordered to pay punitive damages ranging from $50,000 to $4.8 mil. each
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.